AstraZeneca Pharma India Q2 Profit Falls 27%
AstraZeneca Pharma India's net profit for Q2 FY25 declined 27% to Rs 38 crore, while revenue rose to Rs 408 crore. The company's shares closed 3.74% lower on the BSE.
New Delhi, Nov 13 (PTI) AstraZeneca Pharma India on Wednesday said its net profit declined by 27 per cent on-year to Rs 38 crore in the second quarter ended on September 30, 2024.
The drug firm reported a net profit of Rs 52 crore in the July-September quarter of last fiscal.
Revenue from operations stood at Rs 408 crore for the period under review compared with Rs 311 crore in the year-ago period, the firm said in a regulatory filing.
Shares of the company ended 3.74 per cent lower at Rs 7,133.10 apiece on the BSE.
The drug firm reported a net profit of Rs 52 crore in the July-September quarter of last fiscal.
Revenue from operations stood at Rs 408 crore for the period under review compared with Rs 311 crore in the year-ago period, the firm said in a regulatory filing.
Shares of the company ended 3.74 per cent lower at Rs 7,133.10 apiece on the BSE.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 7.91 ( -3.42)
- 63014572
- Srestha Finvest
- 0.55 (+ 1.85)
- 25579372
- Standard Capital
- 0.51 ( -1.92)
- 23892719
- YES Bank Ltd.
- 17.20 ( -4.18)
- 13060858
- GTL Infrastructure
- 1.47 ( -3.92)
- 10225168
MORE NEWS
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback